Related Experiment Video
Updated: May 22, 2025

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
Published on: January 11, 2020
Assertiveness in community pharmacists and their experience of pharmacist-led deprescribing: A cross-sectional study
Mitsuaki Ishii1, Sachiko Ozone2, Shoichi Masumoto2
1Department of Primary Care and Medical Education, Graduate School of Comprehensive Human Sciences, University of Tsukuba, 1-1-1, Tennodai, Tsukuba, Ibaraki, 305-8575, Japan.
Background:
Deprescribing by physicians based on the suggestions of community pharmacists is useful to ensure medication safety. Pharmacist-led deprescribing is not always implemented smoothly because of communication gaps between physicians and pharmacists. Our previous study found that assertiveness, as a communication style, is associated with pharmacist-initiated prescription changes for medication safety; however, its association with community pharmacist-led deprescribing is unclear.
Objectives:
Our objective was to investigate which types of self-expression related to assertiveness are associated with community pharmacist-led deprescribing while adjusting for possible confounding factors.
Methods:
We conducted a cross-sectional survey among community pharmacists between May and October 2022. Participants were community pharmacists belonging to a nationwide pharmacy chain in Japan who worked in 1 of 10 prefectures. The outcome variable was experience of community pharmacist-led deprescribing in the past year. Community pharmacists' self-expression related to assertiveness was assessed using the 3 subdomains of the Interprofessional Assertiveness Scale (IAS): nonassertive, assertive, and aggressive self-expression. Participants were classified into 1 of 2 categories based on median IAS subdomain scores. Pharmacist characteristics were compared by group in univariate analyses. Binomial logistic regression was used to examine the association between experience of community pharmacist-led deprescribing and community pharmacists' assertiveness.
Results:
Of the 3346 community pharmacists invited, 963 were included in the analysis. After adjustment, high assertive self-expression was associated with experience of community pharmacist-led deprescribing (adjusted odds ratio, 1.49; 95 % confidence interval, 1.02-2.20; p = 0.042). No associations were found between experience of community pharmacist-led deprescribing and nonassertive or aggressive self-expression.
Conclusions:
Community pharmacists with higher levels of assertive self-expression were more likely to experience community pharmacist-led deprescribing.
Related Concept Videos
Drug Abuse and Addiction: Pharmacological Phenomena
Drug Therapy
Antianxiety Medications
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Psychosis: Goals of Pharmacotherapy
Desensitization and Tachyphylaxis
Community Based Intervention
Foundations of Community Mental Health Programs
Central to the success of community-based interventions is the...

